1. Home
  2. CPRX
  3. CPRX News

Latest Catalyst Pharmaceuticals Inc. (CPRX) News on June 30, 2025

Catalyst (CPRX) Loses 12.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
CPRX

Zacks

4 days ago

Catalyst (CPRX) Loses 12.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

CPRX

Argus Research

6 days ago

CPRX: Lowering target price to $23.00

CPRX vs. NBIX: Which Stock Is the Better Value Option?
CPRX

Zacks

7 days ago

CPRX vs. NBIX: Which Stock Is the Better Value Option?

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
CPRX

Zacks

11 days ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth
CPRX

Simply Wall St.

12 days ago

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Reports Strong Q1 2025 Earnings Growth

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
CPRX

Zacks

12 days ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock

CPRX

Argus Research

20 days ago

Daily – Vickers Top Buyers & Sellers for 06/11/2025

CPRX

Argus Research

20 days ago

CPRX: Raising target price to $28.00

Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run?
CPRX

Zacks

20 days ago

Catalyst Pharmaceuticals, Inc. (CPRX) Hits Fresh High: Is There Still Room to Run?

Kymera Therapeutics Stock Earns 92 RS Rating
CPRX

Investor's Business Daily

24 days ago

Kymera Therapeutics Stock Earns 92 RS Rating

Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?
CPRX

Zacks

24 days ago

Catalyst (CPRX) Up 11.4% Since Last Earnings Report: Can It Continue?

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
CPRX

Zacks

24 days ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

What Makes Catalyst Pharmaceutical (CPRX) a Strong Momentum Stock: Buy Now?
CPRX

Zacks

a month ago

What Makes Catalyst Pharmaceutical (CPRX) a Strong Momentum Stock: Buy Now?

If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now
CPRX

Zacks

a month ago

If You Invested $1000 in Catalyst Pharmaceutical a Decade Ago, This is How Much It'd Be Worth Now

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Appoints Dr. William Andrews As New Chief Medical Officer
CPRX

Simply Wall St.

a month ago

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Appoints Dr. William Andrews As New Chief Medical Officer

CPRX or NBIX: Which Is the Better Value Stock Right Now?
CPRX

Zacks

a month ago

CPRX or NBIX: Which Is the Better Value Stock Right Now?

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term
CPRX

Zacks

a month ago

Why Catalyst Pharmaceutical (CPRX) is a Top Growth Stock for the Long-Term

Does Catalyst (CPRX) Have the Potential to Rally 36.22% as Wall Street Analysts Expect?
CPRX

Zacks

a month ago

Does Catalyst (CPRX) Have the Potential to Rally 36.22% as Wall Street Analysts Expect?

Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?
CPRX

Zacks

a month ago

Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year?

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term
CPRX

Zacks

a month ago

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
CPRX

GlobeNewswire

a month ago

Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer

CPRX

Argus Research

a month ago

CPRX: Raising target price to $26.00

The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business
CPRX

Simply Wall St.

2 months ago

The Strong Earnings Posted By Catalyst Pharmaceuticals (NASDAQ:CPRX) Are A Good Indication Of The Strength Of The Business

CPRX

Argus Research

2 months ago

CPRX: Raising target price to $25.00

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
CPRX

GuruFocus.com

2 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Compared to Estimates, Catalyst (CPRX) Q1 Earnings: A Look at Key Metrics
CPRX

Zacks

2 months ago

Compared to Estimates, Catalyst (CPRX) Q1 Earnings: A Look at Key Metrics

Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates
CPRX

Zacks

2 months ago

Catalyst Pharmaceutical (CPRX) Q1 Earnings and Revenues Top Estimates

CPRX

Associated Press Finance

2 months ago

Catalyst: Q1 Earnings Snapshot

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update
CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025: Everything You Need To Know Ahead Of Earnings
CPRX

GuruFocus.com

2 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q1 2025: Everything You Need To Know Ahead Of Earnings

CPRX

Argus Research

2 months ago

CPRX: Lowering target price to $24.00

Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know
CPRX

Zacks

2 months ago

Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know

Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: Should You Buy?
CPRX

Zacks

2 months ago

Catalyst Pharmaceutical (CPRX) Earnings Expected to Grow: Should You Buy?

Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?
CPRX

Simply Wall St.

2 months ago

Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025
CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals to Participate in the BofA Securities Health Care Conference 2025

Catalyst Pharmaceuticals, Inc. (CPRX): Among Stocks with Consistent Growth to Buy Now
CPRX

Insider Monkey

2 months ago

Catalyst Pharmaceuticals, Inc. (CPRX): Among Stocks with Consistent Growth to Buy Now

CPRX

Argus Research

2 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025
CPRX

GlobeNewswire

2 months ago

Catalyst Pharmaceuticals to Report First Quarter 2025 Financial Results on May 7, 2025

CPRX

Argus Research

2 months ago

CPRX: Raising target price to $24.00

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?
CPRX

Insider Monkey

3 months ago

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Russell 2000 Stock to Buy According to Wall Street Analysts?

Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?
CPRX

Zacks

3 months ago

Why Is Nektar (NKTR) Down 38.8% Since Last Earnings Report?

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% Dip
CPRX

Simply Wall St.

3 months ago

Catalyst Pharmaceuticals (NasdaqCM:CPRX) Navigates Market Volatility With 3% Dip

CPRX

Argus Research

3 months ago

CPRX: Lowering target price to $22.00

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade
CPRX

Investor's Business Daily

3 months ago

Rhythm Pharmaceuticals Stock Earns RS Rating Upgrade

Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals
CPRX

GlobeNewswire

3 months ago

Catalyst Pharmaceuticals Announces Health Canada’s Acceptance of AGAMREE® New Drug Submission with Priority Review for Sub-Licensee Kye Pharmaceuticals

What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?
CPRX

Insider Monkey

3 months ago

What Makes Catalyst Pharmaceuticals (CPRX) an Investment Choice?

CPRX

Argus Research

3 months ago

CPRX: Lowering target price to $25.00

Catalyst (CPRX) Up 14.7% Since Last Earnings Report: Can It Continue?
CPRX

Zacks

3 months ago

Catalyst (CPRX) Up 14.7% Since Last Earnings Report: Can It Continue?

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win
CPRX

Investor's Business Daily

3 months ago

Catalyst Pharma Battles To All-Time High After Huge Patent Lawsuit Win

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’
CPRX

Insider Monkey

3 months ago

Jim Cramer on Catalyst Pharmaceuticals (CPRX): ‘That’s My Kind of Stock!’

CPRX

Argus Research

3 months ago

CPRX: Raising target price to $27.00

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business
CPRX

Simply Wall St.

3 months ago

With 81% ownership in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), institutional investors have a lot riding on the business

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?
CPRX

Zacks

3 months ago

Catalyst (CPRX) Surges 6.2%: Is This an Indication of Further Gains?

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
CPRX

Zacks

3 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?
CPRX

Insider Monkey

4 months ago

Is Catalyst Pharmaceuticals, Inc. (CPRX) the Best Healthcare Stock For Long-Term Investment?

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative
CPRX

Simply Wall St.

4 months ago

We Think Catalyst Pharmaceuticals' (NASDAQ:CPRX) Robust Earnings Are Conservative

CPRX

Argus Research

4 months ago

CPRX: Raising target price to $24.00

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference
CPRX

GlobeNewswire

4 months ago

Catalyst Pharmaceuticals to Participate in the Barclays 27th Annual Global Healthcare Conference

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations
CPRX

Simply Wall St.

4 months ago

Catalyst Pharmaceuticals Full Year 2024 Earnings: Beats Expectations

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...
CPRX

GuruFocus.com

4 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today
CPRX

Motley Fool

4 months ago

Here's What's Driving Catalyst Pharmaceuticals Stock 8% Higher Today

Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
CPRX

Zacks

4 months ago

Catalyst (CPRX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates
CPRX

Zacks

4 months ago

Catalyst Pharmaceutical (CPRX) Tops Q4 Earnings and Revenue Estimates

CPRX

Associated Press Finance

4 months ago

Catalyst: Q4 Earnings Snapshot

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
CPRX

GlobeNewswire

4 months ago

Catalyst Pharmaceuticals Reports Record Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings
CPRX

GuruFocus.com

4 months ago

Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings

CPRX

Argus Research

4 months ago

CPRX: Rating increased to a BUY

CPRX

Argus Research

4 months ago

CPRX: What does Argus have to say about CPRX?

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90
CPRX

Investor's Business Daily

4 months ago

Recursion Pharmaceuticals Stock Scores RS Ratings Over 90

Incyte Stock Sees Relative Strength Rating Rise To 71
CPRX

Investor's Business Daily

4 months ago

Incyte Stock Sees Relative Strength Rating Rise To 71

Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374%
CPRX

Simply Wall St.

4 months ago

Those who invested in Catalyst Pharmaceuticals (NASDAQ:CPRX) five years ago are up 374%

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025

CPRX

Argus Research

5 months ago

CPRX: What does Argus have to say about CPRX?

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry
CPRX

Investor's Business Daily

5 months ago

This Drug Stock Sits On A Strong Earnings Foundation As It Tests New Entry

Harmony Biosciences Stock Scores 80-Plus RS Rating
CPRX

Investor's Business Daily

5 months ago

Harmony Biosciences Stock Scores 80-Plus RS Rating

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
CPRX

Zacks

5 months ago

How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock
CPRX

Zacks

5 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Momentum Stock

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
CPRX

Zacks

5 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2025 List of America's Most Successful Mid-Cap Companies

Why Investors Need to Take Advantage of These 2 Medical Stocks Now
CPRX

Zacks

5 months ago

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

CPRX

Argus Research

5 months ago

CPRX: Raising target price to $24.00

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
CPRX

Zacks

5 months ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan
CPRX

GlobeNewswire

5 months ago

Catalyst Pharmaceuticals Announces Sub-Licensee DyDo Pharma Launched FIRDAPSE® in Japan

BeiGene Stock Meets 80-Plus RS Rating Benchmark
CPRX

Investor's Business Daily

5 months ago

BeiGene Stock Meets 80-Plus RS Rating Benchmark

CPRX

Argus Research

6 months ago

CPRX: Raising target price to $23.00

BridgeBio Pharma Stock Earns 87 RS Rating
CPRX

Investor's Business Daily

6 months ago

BridgeBio Pharma Stock Earns 87 RS Rating

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?
CPRX

Zacks

6 months ago

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva
CPRX

Investor's Business Daily

6 months ago

IBD Tech Leader Catalyst Rockets After Striking A Key Deal With Teva

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals
CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Teva Pharmaceuticals

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock
CPRX

Zacks

6 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Growth Stock

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
CPRX

Zacks

6 months ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Arcellx Stock Earns 82 Relative Strength Rating
CPRX

Investor's Business Daily

6 months ago

Arcellx Stock Earns 82 Relative Strength Rating

Neurocrine Biosciences Stock Sees RS Rating Upgrade
CPRX

Investor's Business Daily

6 months ago

Neurocrine Biosciences Stock Sees RS Rating Upgrade

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term
CPRX

Zacks

6 months ago

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

CPRX

Argus Research

6 months ago

CPRX: What does Argus have to say about CPRX?

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock
CPRX

Zacks

6 months ago

Here's Why Catalyst Pharmaceutical (CPRX) is a Strong Value Stock

CPRX

Argus Research

6 months ago

CPRX: What does Argus have to say about CPRX?

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CPRX

GlobeNewswire

6 months ago

Catalyst Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

NewAmsterdam Pharma Stock Hits 90-Plus RS Rating
CPRX

Investor's Business Daily

7 months ago

NewAmsterdam Pharma Stock Hits 90-Plus RS Rating

CPRX

Argus Research

7 months ago

CPRX: What does Argus have to say about CPRX?

Share on Social Networks: